Contact Molecules for Homologous Proteins | ||||
[Full Bars] |
[SiteTable] |
|
[Back to Search Page] |
[Back to HOMCOS] |
[SupCon3D] |
[help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
1668648 | 419 | 277 | YP_009724397.2() | |
QUERYSEQ |
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRN PANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA |
419 | region | name | description |
1-419 | DISORDER | predicted by DISOPRED |
MONOMER | |||||||
419 | |||||||
pdb_id | a1 | identity[%]2 | description | ||||
8fd5 | A | 100.0 | NCAP_SARS2 Nucleoprotein | ||||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
HETERO | |||||||
419 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
7n0i[8] | H | Single-domain antibody E2[136 aa] | A | 100.0 /100.0 |
10 /10 |
NCAP_SARS2 Nucleoprotein | |
7n3c[1] | A | S24-202 Fab heavy chain[226 aa] | C | 100.0 /100.0 |
11 /11 |
NCAP_SARS2 Nucleoprotein | |
7n3c[2] | B | S24-202 Fab light chain[214 aa] | C | 100.0 /100.0 |
5 /5 |
NCAP_SARS2 Nucleoprotein | |
7n3d[1] | A | S24-1564 Fab heavy chain[223 aa] | C | 100.0 /100.0 |
12 /12 |
NCAP_SARS2 Nucleoprotein | |
7n3d[1] | B | S24-1564 Fab light chain[213 aa] | C | 100.0 /100.0 |
8 /8 |
NCAP_SARS2 Nucleoprotein | |
7pku[2] | A | A0A6M4N019_SARS2 3C-like proteinase[96 aa] | B | 100.0 /100.0 |
18 /18 |
A0A6G9KDV1_SARS2 Nucleoprotein | |
7wzo[1] | C | R1A_SARS2 nsp3[110 aa] | A | 100.0 /100.0 |
10 /10 |
NCAP_SARS2 Nucleoprotein | |
7r98[3] | D | Nanobody B6[129 aa] | A | 100.0 /100.0 |
14 /14 |
NCAP_SARS2 Nucleoprotein | |
7str[1] | B | Fab S24-1063, Heavy chain[222 aa] | C | 100.0 /100.0 |
11 /11 |
NCAP_SARS2 Nucleoprotein | |
7ylb[8] | C | NC2[84 aa] | A | 100.0 /100.0 |
13 /13 |
NCAP_SARS2 Nucleoprotein | |
7yld[3] | E | NN2[84 aa] | A | 100.0 /100.0 |
12 /12 |
NCAP_SARS2 Nucleoprotein | |
7yld[1] | H | NN2[71 aa] | C | 100.0 /100.0 |
12 /12 |
NCAP_SARS2 Nucleoprotein | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
NUCLEOTIDE | |||||||
419 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
7acs[1] | B | RNA (5'-R(P*CP*AP*CP*UP*GP*AP*C)-3') | A | 100.0 /99.3 |
5 /5 |
NCAP_SARS2 Nucleoprotein | |
7xwz[1] | C | RNA (5'-R(*CP*AP*CP*UP*GP*AP*C)-3') | A | 100.0 /100.0 |
2 /2 |
NCAP_SARS2 Nucleoprotein | |
7acs[1] | C | RNA (5'-R(P*GP*UP*CP*AP*GP*UP*G)-3') | A | 100.0 /99.3 |
11 /11 |
NCAP_SARS2 Nucleoprotein | |
7xwz[2] | D | RNA (5'-R(P*GP*UP*CP*AP*GP*UP*G)-3') | A | 100.0 /100.0 |
8 /8 |
NCAP_SARS2 Nucleoprotein | |
7act[1] | B | ssRNA | A | 100.0 /100.0 |
28 /28 |
NCAP_SARS2 Nucleoprotein | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
COMPOUND | |||||||
419 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
6kl6[1] | E |
DJU
N,N-dimethyl-1-(5-phenylmethoxy-1H-indol-3-yl)meth.. |
B | 83.3 /61.2 |
6 /6 |
A0A0D3MU65_9BETC Nucleoprotein | |
6kl6[1] | E |
DJU
N,N-dimethyl-1-(5-phenylmethoxy-1H-indol-3-yl)meth.. |
D | 57.1 /62.2 |
7 /7 |
A0A0D3MU65_9BETC Nucleoprotein | |
8iv3[1] | E |
DJU
N,N-dimethyl-1-(5-phenylmethoxy-1H-indol-3-yl)meth.. |
A | 100.0 /100.0 |
3 /3 |
NCAP_SARS2 Nucleoprotein | |
8iv3[1] | E |
DJU
N,N-dimethyl-1-(5-phenylmethoxy-1H-indol-3-yl)meth.. |
B | 100.0 /100.0 |
1 /1 |
NCAP_SARS2 Nucleoprotein | |
8iv3[1] | E |
DJU
N,N-dimethyl-1-(5-phenylmethoxy-1H-indol-3-yl)meth.. |
D | 100.0 /100.0 |
4 /4 |
NCAP_SARS2 Nucleoprotein | |
7o35[3] | E |
GTP
GUANOSINE-5'-TRIPHOSPHATE[32 atoms] |
C | 100.0 /100.0 |
4 /4 |
NCAP_SARS2 Nucleoprotein | |
7o35[3] | E |
GTP
GUANOSINE-5'-TRIPHOSPHATE[32 atoms] |
D | 100.0 /100.0 |
4 /4 |
NCAP_SARS2 Nucleoprotein | |
7uxz[1] | G |
GKP
(2R,3R)-2,3-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-.. |
A | 100.0 /100.0 |
8 /8 |
NCAP_SARS2 Nucleoprotein | |
8j6x[1] | E |
U2H
~{N}-methyl-~{N}-[(5-phenylmethoxy-1~{H}-indol-3-y.. |
A | 100.0 /100.0 |
2 /2 |
NCAP_SARS2 Nucleoprotein | |
8j6x[1] | E |
U2H
~{N}-methyl-~{N}-[(5-phenylmethoxy-1~{H}-indol-3-y.. |
B | 100.0 /100.0 |
2 /2 |
NCAP_SARS2 Nucleoprotein | |
8j6x[1] | E |
U2H
~{N}-methyl-~{N}-[(5-phenylmethoxy-1~{H}-indol-3-y.. |
D | 100.0 /100.0 |
4 /4 |
NCAP_SARS2 Nucleoprotein | |
6kl5[1] | E |
DJO
(phenylmethyl) (2S)-2-(hydroxymethyl)-2,3-dihydroi.. |
A | 75.0 /60.5 |
4 /4 |
A0A0D3MU65_9BETC Nucleoprotein | |
6kl5[1] | E |
DJO
(phenylmethyl) (2S)-2-(hydroxymethyl)-2,3-dihydroi.. |
C | 50.0 /62.1 |
4 /4 |
A0A0D3MU65_9BETC Nucleoprotein | |
7dyd[1] | E |
EY3
5-propan-2-yloxy-1H-indole[13 atoms] |
B | 100.0 /59.8 |
1 /1 |
A0A2I2MQD0_9BETC Nucleoprotein | |
7dyd[1] | E |
EY3
5-propan-2-yloxy-1H-indole[13 atoms] |
D | 83.3 /61.8 |
6 /6 |
A0A2I2MQD0_9BETC Nucleoprotein | |
6lz8[1] | E |
EY9
5-(2-methoxyethoxy)-1H-indole[14 atoms] |
C | 50.0 /59.8 |
2 /2 |
A0A2I2MQD0_9BETC Nucleoprotein | |
6lz8[1] | E |
EY9
5-(2-methoxyethoxy)-1H-indole[14 atoms] |
D | 100.0 /61.6 |
3 /3 |
A0A2I2MQD0_9BETC Nucleoprotein | |
6lnn[1] | E |
EJC
5-propoxy-1H-indole[13 atoms] |
B | 100.0 /60.8 |
1 /1 |
A0A2I2MQD0_9BETC Nucleoprotein | |
6lnn[1] | E |
EJC
5-propoxy-1H-indole[13 atoms] |
D | 100.0 /61.3 |
5 /5 |
A0A2I2MQD0_9BETC Nucleoprotein | |
6lz6[1] | E |
EY6
5-(2-fluoranylethoxy)-1H-indole[13 atoms] |
B | 100.0 /59.8 |
1 /1 |
A0A2I2MQD0_9BETC Nucleoprotein | |
6lz6[1] | E |
EY6
5-(2-fluoranylethoxy)-1H-indole[13 atoms] |
D | 100.0 /60.9 |
7 /7 |
A0A2I2MQD0_9BETC Nucleoprotein | |
4li4[1] | B |
AMP
ADENOSINE MONOPHOSPHATE[23 atoms] |
A | 80.0 /50.0 |
10 /14 |
Q6SA23_CVHOC Nucleoprotein | |
4lm7[1] | B |
U5P
URIDINE-5'-MONOPHOSPHATE[21 atoms] |
A | 80.0 /50.0 |
10 /14 |
Q6SA23_CVHOC Nucleoprotein | |
4lmt[1] | B |
CQD
6-chloro-7-{[2-(morpholin-4-yl)ethyl]amino}quinoli.. |
A | 83.3 /49.6 |
6 /10 |
Q6SA23_CVHOC Nucleoprotein | |
4lm9[1] | B |
5GP
GUANOSINE-5'-MONOPHOSPHATE[24 atoms] |
A | 80.0 /49.6 |
10 /14 |
Q6SA23_CVHOC Nucleoprotein | |
4lmc[1] | B |
C5P
CYTIDINE-5'-MONOPHOSPHATE[21 atoms] |
A | 88.9 /49.6 |
9 /13 |
Q6SA23_CVHOC Nucleoprotein | |
4kxj[1] | B |
P34
N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTH.. |
A | 50.0 /49.2 |
6 /10 |
Q6SA23_CVHOC Nucleoprotein | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
METAL | |||||||
419 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
6g13[2] | I |
CL
CHLORIDE ION[1 atoms] |
B | 50.0 /55.1 |
2 /2 |
A0A0D3MU51_9BETC Nucleoprotein | |
6vyo[4] | F |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /100.0 |
1 /1 |
NCAP_SARS2 Nucleoprotein | |
6vyo[4] | I |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /100.0 |
3 /3 |
NCAP_SARS2 Nucleoprotein | |
6wji[6] | G |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /100.0 |
1 /1 |
NCAP_SARS2 Nucleoprotein | |
6wji[4] | H |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /100.0 |
1 /1 |
NCAP_SARS2 Nucleoprotein | |
6wji[3] | K |
CL
CHLORIDE ION[1 atoms] |
D | 100.0 /100.0 |
2 /2 |
NCAP_SARS2 Nucleoprotein | |
7n3d[1] | O |
CL
CHLORIDE ION[1 atoms] |
C | 100.0 /100.0 |
2 /2 |
NCAP_SARS2 Nucleoprotein | |
7n3d[1] | P |
CL
CHLORIDE ION[1 atoms] |
C | 100.0 /100.0 |
2 /2 |
NCAP_SARS2 Nucleoprotein | |
7uxz[1] | L |
CL
CHLORIDE ION[1 atoms] |
E | 100.0 /100.0 |
1 /1 |
NCAP_SARS2 Nucleoprotein | |
6vyo[12] | H |
ZN
ZINC ION[1 atoms] |
A | 100.0 /100.0 |
3 /3 |
NCAP_SARS2 Nucleoprotein | |
6vyo[8] | J |
ZN
ZINC ION[1 atoms] |
A | 100.0 /100.0 |
1 /1 |
NCAP_SARS2 Nucleoprotein | |
7xx1[4] | J |
ZN
ZINC ION[1 atoms] |
A | 100.0 /100.0 |
1 /1 |
NCAP_SARS2 Nucleoprotein | |
7n0i[1] | N |
MG
MAGNESIUM ION[1 atoms] |
D | 100.0 /100.0 |
3 /3 |
NCAP_SARS2 Nucleoprotein | |
7n3c[1] | T |
IOD
IODIDE ION[1 atoms] |
C | 100.0 /100.0 |
3 /3 |
NCAP_SARS2 Nucleoprotein | |
7n3c[1] | U |
IOD
IODIDE ION[1 atoms] |
C | 100.0 /100.0 |
2 /2 |
NCAP_SARS2 Nucleoprotein | |
7n3c[1] | V |
IOD
IODIDE ION[1 atoms] |
C | 100.0 /100.0 |
1 /1 |
NCAP_SARS2 Nucleoprotein | |
7n3c[1] | W |
IOD
IODIDE ION[1 atoms] |
C | 100.0 /100.0 |
4 /4 |
NCAP_SARS2 Nucleoprotein | |
7n3c[1] | X |
IOD
IODIDE ION[1 atoms] |
C | 100.0 /100.0 |
2 /2 |
NCAP_SARS2 Nucleoprotein | |
7uxz[1] | J |
NA
SODIUM ION[1 atoms] |
A | 100.0 /100.0 |
2 /2 |
NCAP_SARS2 Nucleoprotein | |
4ud1[3] | F |
NH4
AMMONIUM ION[1 atoms] |
A | 0.0 /59.1 |
2 /2 |
T2B9R0_9BETC N PROTEIN | |
4ud1[1] | J |
NH4
AMMONIUM ION[1 atoms] |
C | 100.0 /59.1 |
1 /1 |
T2B9R0_9BETC N PROTEIN | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
HOMO | |||||||
419 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
2cjr[108] | B | NCAP_CVHSA NUCLEOCAPSID PROTEIN[113 aa] | A | 98.1 /95.7 |
52 /52 |
NCAP_CVHSA NUCLEOCAPSID PROTEIN | |
2gib[2] | A | NCAP_CVHSA Nucleocapsid protein[97 aa] | A | 100.0 /95.9 |
8 /8 |
NCAP_CVHSA Nucleocapsid protein | |
2gib[2] | A | NCAP_CVHSA Nucleocapsid protein[97 aa] | A | 100.0 /95.9 |
6 /6 |
NCAP_CVHSA Nucleocapsid protein | |
2gib[2] | B | NCAP_CVHSA Nucleocapsid protein[96 aa] | A | 100.0 /95.9 |
1 /1 |
NCAP_CVHSA Nucleocapsid protein | |
2gib[2] | A | NCAP_CVHSA Nucleocapsid protein[97 aa] | B | 100.0 /95.8 |
3 /3 |
NCAP_CVHSA Nucleocapsid protein | |
6vyo[122] | B | NCAP_SARS2 Nucleoprotein[125 aa] | A | 100.0 /100.0 |
12 /12 |
NCAP_SARS2 Nucleoprotein | |
6vyo[12] | D | NCAP_SARS2 Nucleoprotein[125 aa] | A | 100.0 /100.0 |
9 /9 |
NCAP_SARS2 Nucleoprotein | |
7xx1[4] | D | NCAP_SARS2 Nucleoprotein[119 aa] | A | 100.0 /100.0 |
8 /8 |
NCAP_SARS2 Nucleoprotein | |
8iv3[2] | B | NCAP_SARS2 Nucleoprotein[128 aa] | A | 100.0 /100.0 |
6 /6 |
NCAP_SARS2 Nucleoprotein | |
8iv3[2] | C | NCAP_SARS2 Nucleoprotein[128 aa] | A | 100.0 /100.0 |
10 /10 |
NCAP_SARS2 Nucleoprotein | |
8iv3[2] | D | NCAP_SARS2 Nucleoprotein[126 aa] | A | 100.0 /100.0 |
11 /11 |
NCAP_SARS2 Nucleoprotein | |
8iv3[4] | A | NCAP_SARS2 Nucleoprotein[126 aa] | B | 100.0 /100.0 |
10 /10 |
NCAP_SARS2 Nucleoprotein | |
8iv3[2] | C | NCAP_SARS2 Nucleoprotein[128 aa] | B | 100.0 /100.0 |
6 /6 |
NCAP_SARS2 Nucleoprotein | |
8iv3[2] | D | NCAP_SARS2 Nucleoprotein[126 aa] | B | 100.0 /100.0 |
4 /4 |
NCAP_SARS2 Nucleoprotein | |
8iv3[4] | A | NCAP_SARS2 Nucleoprotein[126 aa] | C | 100.0 /100.0 |
8 /8 |
NCAP_SARS2 Nucleoprotein | |
8x1h[48] | A | NCAP_SARS2 Nucleoprotein[128 aa] | A | 100.0 /100.0 |
128 /128 |
NCAP_SARS2 Nucleoprotein | |
8x1h[16] | A | NCAP_SARS2 Nucleoprotein[128 aa] | B | 100.0 /100.0 |
13 /13 |
NCAP_SARS2 Nucleoprotein | |
8x1h[16] | D | NCAP_SARS2 Nucleoprotein[122 aa] | C | 100.0 /100.0 |
1 /1 |
NCAP_SARS2 Nucleoprotein | |
8x1h[16] | C | NCAP_SARS2 Nucleoprotein[127 aa] | D | 100.0 /100.0 |
1 /1 |
NCAP_SARS2 Nucleoprotein | |
7f2e[1] | F | NCAP_SARS2 Nucleoprotein[97 aa] | E | 100.0 /100.0 |
43 /43 |
NCAP_SARS2 Nucleoprotein | |
7f2e[1] | L | NCAP_SARS2 Nucleoprotein[92 aa] | K | 100.0 /100.0 |
41 /41 |
NCAP_SARS2 Nucleoprotein | |
6kl2[12] | C | A0A0D3MU65_9BETC Nucleoprotein[104 aa] | A | 57.1 /61.4 |
7 /9 |
A0A0D3MU65_9BETC Nucleoprotein | |
6lnn[16] | C | A0A2I2MQD0_9BETC Nucleoprotein[114 aa] | A | 66.7 /59.5 |
9 /12 |
A0A2I2MQD0_9BETC Nucleoprotein | |
6g13[4] | C | A0A0D3MU51_9BETC Nucleoprotein[113 aa] | A | 63.0 /55.2 |
54 /55 |
A0A0D3MU51_9BETC Nucleoprotein | |
5n4k[2] | B | NCAP_CVHNL Nucleoprotein[129 aa] | A | 41.7 /46.0 |
12 /22 |
NCAP_CVHNL Nucleoprotein | |
2gec[1] | B | NCAP_IBVG Nucleocapsid protein[139 aa] | A | 27.8 /40.7 |
18 /18 |
NCAP_IBVG Nucleocapsid protein | |
2gec[1] | A | NCAP_IBVG Nucleocapsid protein[138 aa] | B | 35.0 /40.7 |
20 /25 |
NCAP_IBVG Nucleocapsid protein | |
5epw[2] | B | NCAP_CVHNL Nucleoprotein[110 aa] | A | 31.4 /38.0 |
51 /54 |
NCAP_CVHNL Nucleoprotein | |
8ym1[8] | F | nucleocapsid phosphoprotein[103 aa] | A | 31.4 /34.1 |
51 /52 |
nucleocapsid phosphoprotein | |
8wqk[8] | D | NCAP_PEDV7 Nucleoprotein[100 aa] | A | 26.8 /32.0 |
56 /56 |
NCAP_PEDV7 Nucleoprotein | |
2ge7[10] | B | NCAP_IBVG Nucleocapsid protein[108 aa] | A | 35.1 /29.1 |
57 /59 |
NCAP_IBVG Nucleocapsid protein | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
PRECIPITANT | |||||||
419 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
2gib[5] | C |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /95.9 |
2 /2 |
NCAP_CVHSA Nucleocapsid protein | |
5n4k[4] | D |
SO4
SULFATE ION[5 atoms] |
A | 66.7 /46.0 |
3 /3 |
NCAP_CVHNL Nucleoprotein | |
5n4k[1] | I |
SO4
SULFATE ION[5 atoms] |
A | 50.0 /46.0 |
2 /2 |
NCAP_CVHNL Nucleoprotein | |
5n4k[7] | J |
SO4
SULFATE ION[5 atoms] |
A | 50.0 /46.0 |
2 /4 |
NCAP_CVHNL Nucleoprotein | |
5n4k[2] | K |
SO4
SULFATE ION[5 atoms] |
A | 0.0 /46.0 |
2 /2 |
NCAP_CVHNL Nucleoprotein | |
6wzq[1] | F |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /100.0 |
1 /1 |
NCAP_SARS2 Nucleoprotein | |
6wzq[3] | G |
SO4
SULFATE ION[5 atoms] |
B | 100.0 /100.0 |
1 /1 |
NCAP_SARS2 Nucleoprotein | |
6wzq[1] | I |
SO4
SULFATE ION[5 atoms] |
C | 100.0 /100.0 |
3 /3 |
NCAP_SARS2 Nucleoprotein | |
2ofz[1] | B |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /92.1 |
2 /2 |
NCAP_CVHSA Nucleocapsid protein | |
7n3c[1] | M |
EDO
1,2-ETHANEDIOL[4 atoms] |
C | 100.0 /100.0 |
1 /1 |
NCAP_SARS2 Nucleoprotein | |
7n3c[1] | R |
EDO
1,2-ETHANEDIOL[4 atoms] |
C | 100.0 /100.0 |
3 /3 |
NCAP_SARS2 Nucleoprotein | |
7n3c[1] | S |
EDO
1,2-ETHANEDIOL[4 atoms] |
C | 100.0 /100.0 |
5 /5 |
NCAP_SARS2 Nucleoprotein | |
7n3d[1] | K |
EDO
1,2-ETHANEDIOL[4 atoms] |
C | 100.0 /100.0 |
2 /2 |
NCAP_SARS2 Nucleoprotein | |
7n3d[2] | L |
EDO
1,2-ETHANEDIOL[4 atoms] |
C | 100.0 /100.0 |
5 /5 |
NCAP_SARS2 Nucleoprotein | |
7n3d[1] | M |
EDO
1,2-ETHANEDIOL[4 atoms] |
C | 100.0 /100.0 |
5 /5 |
NCAP_SARS2 Nucleoprotein | |
7n3d[1] | N |
EDO
1,2-ETHANEDIOL[4 atoms] |
C | 100.0 /100.0 |
3 /3 |
NCAP_SARS2 Nucleoprotein | |
7str[1] | D |
EDO
1,2-ETHANEDIOL[4 atoms] |
C | 100.0 /100.0 |
1 /1 |
NCAP_SARS2 Nucleoprotein | |
7str[1] | G |
EDO
1,2-ETHANEDIOL[4 atoms] |
C | 100.0 /100.0 |
5 /5 |
NCAP_SARS2 Nucleoprotein | |
7xwz[2] | G |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /100.0 |
3 /3 |
NCAP_SARS2 Nucleoprotein | |
4ud1[2] | I |
GOL
GLYCEROL[6 atoms] |
B | 66.7 /59.1 |
3 /3 |
T2B9R0_9BETC N PROTEIN | |
4ud1[5] | M |
GOL
GLYCEROL[6 atoms] |
D | 0.0 /60.7 |
3 /3 |
T2B9R0_9BETC N PROTEIN | |
6vyo[3] | K |
GOL
GLYCEROL[6 atoms] |
B | 100.0 /100.0 |
3 /3 |
NCAP_SARS2 Nucleoprotein | |
6vyo[2] | P |
GOL
GLYCEROL[6 atoms] |
C | 100.0 /100.0 |
6 /6 |
NCAP_SARS2 Nucleoprotein | |
7o36[1] | F |
GOL
GLYCEROL[6 atoms] |
B | 100.0 /100.0 |
9 /9 |
NCAP_SARS2 Nucleoprotein | |
7uxx[1] | G |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
4 /4 |
NCAP_SARS2 Nucleoprotein | |
7uxx[17] | G |
GOL
GLYCEROL[6 atoms] |
C | 100.0 /100.0 |
2 /2 |
NCAP_SARS2 Nucleoprotein | |
7uxx[3] | J |
GOL
GLYCEROL[6 atoms] |
F | 100.0 /100.0 |
4 /4 |
NCAP_SARS2 Nucleoprotein | |
7xwz[1] | I |
GOL
GLYCEROL[6 atoms] |
B | 100.0 /100.0 |
6 /6 |
NCAP_SARS2 Nucleoprotein | |
6g13[1] | G |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 80.0 /55.2 |
5 /5 |
A0A0D3MU51_9BETC Nucleoprotein | |
7c22[1] | F |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /100.0 |
3 /3 |
NCAP_SARS2 Nucleoprotein | |
7de1[1] | C |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
B | 100.0 /100.0 |
5 /5 |
NCAP_SARS2 Nucleoprotein | |
7de1[2] | D |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
B | 100.0 /100.0 |
2 /2 |
NCAP_SARS2 Nucleoprotein | |
7uxz[2] | H |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /100.0 |
4 /4 |
NCAP_SARS2 Nucleoprotein | |
7uxz[1] | H |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
B | 100.0 /100.0 |
1 /1 |
NCAP_SARS2 Nucleoprotein | |
6vyo[6] | E |
MES
2-(N-MORPHOLINO)-ETHANESULFONIC ACID[12 atoms] |
A | 100.0 /100.0 |
5 /5 |
NCAP_SARS2 Nucleoprotein | |
6vyo[6] | G |
MES
2-(N-MORPHOLINO)-ETHANESULFONIC ACID[12 atoms] |
A | 100.0 /100.0 |
3 /3 |
NCAP_SARS2 Nucleoprotein | |
7xx1[4] | G |
MES
2-(N-MORPHOLINO)-ETHANESULFONIC ACID[12 atoms] |
A | 100.0 /100.0 |
4 /4 |
NCAP_SARS2 Nucleoprotein | |
7xx1[4] | L |
MES
2-(N-MORPHOLINO)-ETHANESULFONIC ACID[12 atoms] |
A | 100.0 /100.0 |
1 /1 |
NCAP_SARS2 Nucleoprotein | |
7c22[2] | E |
ACT
ACETATE ION[4 atoms] |
A | 100.0 /100.0 |
2 /2 |
NCAP_SARS2 Nucleoprotein | |
7c22[2] | E |
ACT
ACETATE ION[4 atoms] |
B | 100.0 /100.0 |
1 /1 |
NCAP_SARS2 Nucleoprotein | |
7n0i[1] | M |
ACT
ACETATE ION[4 atoms] |
C | 100.0 /100.0 |
3 /3 |
NCAP_SARS2 Nucleoprotein | |
7n0i[1] | M |
ACT
ACETATE ION[4 atoms] |
D | 100.0 /100.0 |
2 /2 |
NCAP_SARS2 Nucleoprotein | |
7n0i[1] | O |
ACT
ACETATE ION[4 atoms] |
L | 100.0 /100.0 |
2 /2 |
NCAP_SARS2 Nucleoprotein | |
7uxx[1] | I |
ACT
ACETATE ION[4 atoms] |
B | 100.0 /100.0 |
3 /3 |
NCAP_SARS2 Nucleoprotein | |
7uxx[1] | I |
ACT
ACETATE ION[4 atoms] |
D | 100.0 /100.0 |
2 /2 |
NCAP_SARS2 Nucleoprotein | |
7vnu[1] | E |
ACT
ACETATE ION[4 atoms] |
C | 100.0 /100.0 |
3 /3 |
NCAP_SARS2 Nucleoprotein | |
7f2b[2] | C |
PO4
PHOSPHATE ION[5 atoms] |
A | 100.0 /100.0 |
1 /1 |
NCAP_SARS2 Nucleoprotein | |
7f2b[3] | D |
PO4
PHOSPHATE ION[5 atoms] |
A | 100.0 /100.0 |
2 /2 |
NCAP_SARS2 Nucleoprotein | |
7f2b[1] | F |
PO4
PHOSPHATE ION[5 atoms] |
B | 100.0 /100.0 |
5 /5 |
NCAP_SARS2 Nucleoprotein | |
7f2b[1] | H |
PO4
PHOSPHATE ION[5 atoms] |
B | 100.0 /100.0 |
3 /3 |
NCAP_SARS2 Nucleoprotein | |
7f2e[4] | M |
PO4
PHOSPHATE ION[5 atoms] |
G | 100.0 /100.0 |
3 /3 |
NCAP_SARS2 Nucleoprotein | |
7f2e[4] | M |
PO4
PHOSPHATE ION[5 atoms] |
H | 100.0 /100.0 |
1 /1 |
NCAP_SARS2 Nucleoprotein | |
7xwx[3] | I |
PO4
PHOSPHATE ION[5 atoms] |
A | 100.0 /100.0 |
2 /2 |
NCAP_SARS2 Nucleoprotein | |
4ud1[2] | H |
IMD
IMIDAZOLE[5 atoms] |
B | 100.0 /59.1 |
3 /3 |
T2B9R0_9BETC N PROTEIN | |
6g13[1] | E |
TMO
trimethylamine oxide[5 atoms] |
A | 0.0 /55.2 |
1 /1 |
A0A0D3MU51_9BETC Nucleoprotein | |
6g13[3] | F |
TMO
trimethylamine oxide[5 atoms] |
A | 66.7 /55.2 |
3 /3 |
A0A0D3MU51_9BETC Nucleoprotein | |
4j3k[1] | B |
TRS
2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL[8 atoms] |
A | 44.4 /50.0 |
9 /9 |
Q6SA23_CVHOC Nucleoprotein | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. |